(Q52344095)
Statements
Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity. (English)
1 reference
Rayan S Moussa
1 reference
Kyung Chan Park
1 reference
Zaklina Kovacevic
1 reference
20 March 2018
1 reference
1 reference
1 reference